United States  

Hydroxychloroquine

Antimalarial medication

Hydroxychloroquine    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Hydroxychloroquine: Antimalarial medication
Hydroxychloroquine (HCQ), sold under the brand name Plaquenil among others, is a medication used to prevent and treat malaria in areas where malaria remains sensitive to chloroquine. Other uses include treatment of rheumatoid arthritis, lupus, and porphyria cutanea tarda. It is taken by mouth. HCQ is being studied to prevent and treat coronavirus disease 2019 (COVID‑19). High-quality evidence of benefit for such use is lacking, with concerns of potential harms from side effects.

0
shares
ShareTweetSavePostSend
 

Happy that WHO resumed trials of HCQ: CISR [Video]

Happy that WHO resumed trials of HCQ: CISR

World Health Organisation (WHO) has resumed trials of hydroxychloroquine (HCQ). Speaking on it, Director General of Council of Scientific an Industrial Research (CSIR), Dr. Shekhar C Mande said, "We..

Credit: ANI     Duration: 01:16Published
COVID-19: CSIR DG supports ICMR over WHO's decision on HCQ clinical trials [Video]

COVID-19: CSIR DG supports ICMR over WHO's decision on HCQ clinical trials

While commenting on World Health Organisation's decision to temporarily suspend clinical trials of hydroxychloroquine, Director General of Council of Scientific and Industrial Research (CSIR), Shekhar..

Credit: ANI     Duration: 01:43Published

You Might Like


Trump’s Inaccurate Claims on Hydroxychloroquine

The president falsely described scientific research around the malaria drug, falsely denied the existence of a federal warning against it and argued, with no evidence, that large numbers of health care..
NYTimes.com - Published

Search this site and the web: